The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 28, 2021

Filed:

Jun. 27, 2018
Applicant:

Nektar Therapeutics, San Francisco, CA (US);

Inventors:

C. Simone Jude-Fishburn, Redwood City, CA (US);

David Lechuga-Ballesteros, San Jose, CA (US);

Tacey X. Viegas, Madison, AL (US);

Mei-Chang Kuo, Palo Alto, CA (US);

Hema Gursahani, Foster City, CA (US);

Chester Leach, Tijeras, NM (US);

Yuan Song, Belmont, CA (US);

Assignee:

Nektar Therapeutics, San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 47/60 (2017.01); A61K 31/167 (2006.01); A61K 31/485 (2006.01); C07C 41/24 (2006.01);
U.S. Cl.
CPC ...
A61K 9/007 (2013.01); A61K 31/167 (2013.01); A61K 31/485 (2013.01); A61K 47/60 (2017.08); C07C 41/24 (2013.01);
Abstract

Methods of modifying the rate of systemic absorption of a drug administered to a subject by a pulmonary route, the method comprising covalently conjugating a hydrophilic polymer to a drug, wherein the drug has a half-life of elimination from the lung of less than about 180 minutes, to form a drug-polymer conjugate, wherein the drug-polymer conjugate has a net hydrophilic character and a weight average molecular weight of from about 50 to about 20,000 Daltons, and wherein the half-life of elimination from the lung of the drug-polymer conjugate is at least about 1.5-fold greater than the half-life of elimination from the lung of the drug, wherein the half-life of elimination from the lung is measured by bronchioalveolar lavage followed by assaying residual lung material.


Find Patent Forward Citations

Loading…